UK Markets closed

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
24.18-0.30 (-1.23%)
At close: 04:00PM EDT
24.02 -0.16 (-0.66%)
After hours: 07:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.86
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 377.72
52-week low 323.22
50-day moving average 329.18
200-day moving average 342.32

Share statistics

Avg vol (3-month) 32.04M
Avg vol (10-day) 32.39M
Shares outstanding 5102.44M
Implied shares outstanding 6N/A
Float 897.59M
% held by insiders 14.68%
% held by institutions 193.57%
Shares short (30 Jan 2023) 45.53M
Short ratio (30 Jan 2023) 43.52
Short % of float (30 Jan 2023) 47.29%
Short % of shares outstanding (30 Jan 2023) 45.40%
Shares short (prior month 29 Dec 2022) 45.1M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin -140.58%
Operating margin (ttm)-114.71%

Management effectiveness

Return on assets (ttm)-15.73%
Return on equity (ttm)-125.48%

Income statement

Revenue (ttm)430.76M
Revenue per share (ttm)4.22
Quarterly revenue growth (yoy)23.90%
Gross profit (ttm)250.74M
EBITDA -462.23M
Net income avi to common (ttm)-605.56M
Diluted EPS (ttm)-2.60
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)958.04M
Total cash per share (mrq)9.35
Total debt (mrq)1.37B
Total debt/equity (mrq)823.66
Current ratio (mrq)6.46
Book value per share (mrq)12.96

Cash flow statement

Operating cash flow (ttm)-295.7M
Levered free cash flow (ttm)-275.02M